LUNG CANCER FOUNDATION OF AMERICA

EIN: 208730839 501(c)(3) Diseases & Disorders

LOS ANGELES, CA

Total Revenue
$2,334,021
Total Expenses
$2,096,572
Total Assets
$2,114,168
Net Assets
$1,505,760
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2007
Legal Domicile
MN
Principal Officer
JIM BARANSKI
Phone
5073541361
Tax Period
2024-01-01 to 2024-12-31

LUNG CANCER FOUNDATION OF AMERICA, founded in 2007, is a community nonprofit in the Diseases & Disorders sector that reported $2.3M in total revenue in fiscal year 2024. Expenses of $2.1M left a modest 10% surplus.

Mission

LUNG CANCER FOUNDATION OF AMERICA (LCFA) IS WORKING TO CHANGE THE PUBLIC PERCEPTION OF LUNG CANCER THROUGH EDUCATION AND PERSONAL STORIES ABOUT LUNG CANCER AND TO IMPROVE PATIENT OUTCOMES THROUGH FUNDING IMPACTFUL RESEARCH.

Program Service Accomplishments

Program 1
Expenses: $1,085,177

RESEARCH GRANT & SCIENTIFIC ADVANCMENTS: RESEARCH GRANTS: AWARDED MULTIPLE SIX-FIGURE LUNG CANCER RESEARCH GRANTS TO YOUNG INVESTIGATORS, FOCUSING ON EARLY DETECTION, TARGETED THERAPIES, AND...

Read more

RESEARCH GRANT & SCIENTIFIC ADVANCMENTS: RESEARCH GRANTS: AWARDED MULTIPLE SIX-FIGURE LUNG CANCER RESEARCH GRANTS TO YOUNG INVESTIGATORS, FOCUSING ON EARLY DETECTION, TARGETED THERAPIES, AND IMMUNOTHERAPY. THESE GRANTS, MADE POSSIBLE THROUGH GENEROUS PRIVATE DONATIONS, HAVE LED TO GROUNDBREAKING DISCOVERIES IN LUNG CANCER TREATMENT. SCIENTIFIC ADVANCEMENTS: SUPPORTED RESEARCH THAT CONTRIBUTED TO SIGNIFICANT PROGRESS IN PERSONALIZED TREATMENT STRATEGIES, INCLUDING ADVANCEMENTS IN TARGETED THERAPIES AND IMMUNOTHERAPY FOR BOTH NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC).

Program 2
Expenses: $834,837

AWARENESS INITIATIVES, SPEAKERS BUREAU, FUNDRAISING SUCCESS, & COLLABORATIVE PARTNERSHIPS: AWARENESS INITIATIVES: REACHED MILLIONS OF PEOPLE THROUGH COMPREHENSIVE AWARENESS-RAISING CAMPAIGNS...

Read more

AWARENESS INITIATIVES, SPEAKERS BUREAU, FUNDRAISING SUCCESS, & COLLABORATIVE PARTNERSHIPS: AWARENESS INITIATIVES: REACHED MILLIONS OF PEOPLE THROUGH COMPREHENSIVE AWARENESS-RAISING CAMPAIGNS, EDUCATING THE PUBLIC ABOUT LUNG CANCER RISK FACTORS, EARLY DETECTION, AND TREATMENT OPTIONS.SCIENTIFIC ADVANCEMENTS: SUPPORTED RESEARCH THAT CONTRIBUTED TO SIGNIFICANT PROGRESS IN PERSONALIZED TREATMENT STRATEGIES, INCLUDING ADVANCEMENTS IN TARGETED THERAPIES AND IMMUNOTHERAPY FOR BOTH NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC). FUNDRAISING SUCCESS: SUCCESSFULLY RAISED FUNDS TO SUPPORT ONGOING RESEARCH INITIATIVES AND AWARENESS PROGRAMS, DEMONSTRATING STRONG DONOR ENGAGEMENT AND FINANCIAL STEWARDSHIP. COLLABORATIVE PARTNERSHIPS: STRENGTHENED PARTNERSHIPS WITH SISTER ORGANIZATIONS TO MAXIMIZE THE IMPACT OF RESEARCH FUNDING AND ADVOCACY EFFORTS. THROUGH THESE ACCOMPLISHMENTS, LCFA HAS CONTINUED TO MAKE SIGNIFICANT STRIDES IN IMPROVING LUNG CANCER OUTCOMES AND SUPPORTING THE LUNG CANCER COMMUNITY.

Program 3
Expenses: $25,948

COMMUNITY ENGAGEMENT: FOSTERED A SUPPORTIVE COMMUNITY FOR LUNG CANCER PATIENTS AND THEIR FAMILIES THROUGH EDUCATIONAL RESOURCES, SUPPORT PROGRAMS, AND ADVOCACY EFFORTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,300,119
Program Service Revenue $0
Investment Income $33,902
Other Revenue $0
TOTAL REVENUE $2,334,021

Expense Breakdown

Grants Paid $400,000
Salaries & Benefits $615,984
Fundraising Expenses $99,521
Program Expenses $1,945,962
Other Expenses $1,080,588
TOTAL EXPENSES $2,096,572

Year-over-Year Comparison

2024 2023 Change
Revenue $2,334,021 $2,265,637 +0.0%
Expenses $2,096,572 $1,854,172 +0.1%
Net Income $237,449 $411,465 -0.4%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
10
Independent Members
8
Employees
7
Volunteers
225

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
3
$313,704
Total Directors
10
$313,704
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JIM BARANSKI EXECUTIVE DIRECTOR 40.00
Officer Director
$200,000 $8,002 $208,002
KIM NORRIS PRESIDENT 40.00
Officer Director
$100,000 $5,702 $105,702
SUSAN MANDEL MD SECRETARY 10.00
Officer Director
$0 $0 $0
MARTA KAUFFMAN DIRECTOR 1.00
Director
$0 $0 $0
ROBERT FIGLIN MD FACP DIRECTOR 1.00
Director
$0 $0 $0
DAVID T LEVINSON DIRECTOR 1.00
Director
$0 $0 $0
MARTIN EDELMAN DIRECTOR 1.00
Director
$0 $0 $0
CAROLYN ZAINER DIRECTOR 1.00
Director
$0 $0 $0
MICHELLE SAYER DIRECTOR 1.00
Director
$0 $0 $0
TRISH COURY DIRECTOR 1.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $2,334,021 $2,096,572 $2,114,168 $237,449
2023 $2,265,637 $1,854,172 $1,548,034 $411,465
2022 $1,540,536 $1,548,582 $1,180,746 $-8,046
2021 $1,298,335 $1,089,710 $1,303,793 $208,625
2020 $1,432,839 $1,351,529 $1,558,916 $81,310
2019 $1,003,191 $1,308,962 $1,317,950 $-305,771
2018 $1,353,237 $1,085,709 $1,316,759 $267,528
Explore More Nonprofits
Top 100 Nonprofits in California Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare LUNG CANCER FOUNDATION OF AMERICA with other nonprofits in California and across the country.